Detalhe da pesquisa
1.
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.
Cancer Cell Int
; 22(1): 400, 2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503426
2.
Loss of function effect of RET mutations causing Hirschsprung disease.
Nat Genet
; 10(1): 35-40, 1995 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-7647787
3.
SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
Oncogene
; 26(45): 6546-59, 2007 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-17471236
4.
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
Mol Cell Biol
; 13(1): 358-66, 1993 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-7678053
5.
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
Mol Cell Biol
; 16(5): 2151-63, 1996 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8628282
6.
DNA methylation affecting the transforming activity of the human Ha-ras oncogene.
Cancer Res
; 47(1): 75-9, 1987 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2431768
7.
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
Cancer Res
; 54(11): 2979-85, 1994 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8187085
8.
Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Cancer Res
; 45(10): 4980-5, 1985 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-2992769
9.
Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.
Cancer Res
; 49(17): 4901-5, 1989 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2503246
10.
Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Oncogene
; 7(3): 405-9, 1992 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-1312699
11.
Grb2 binding to the different isoforms of Ret tyrosine kinase.
Oncogene
; 17(9): 1079-87, 1998 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-9764818
12.
HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Oncogene
; 2(1): 91-5, 1987.
Artigo
em Inglês
| MEDLINE | ID: mdl-2894003
13.
DNA methylation of coding and non-coding regions of the human H-RAS gene in normal and tumor tissues.
Oncogene
; 7(2): 269-75, 1992 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-1549348
14.
Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
Oncogene
; 20(27): 3475-85, 2001 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-11429694
15.
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Oncogene
; 16(18): 2295-301, 1998 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-9620546
16.
The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein.
Oncogene
; 18(34): 4833-8, 1999 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-10490816
17.
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
Oncogene
; 15(19): 2257-65, 1997 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-9393871
18.
The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins.
Oncogene
; 9(6): 1661-8, 1994 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-8183561
19.
Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Oncogene
; 7(11): 2189-94, 1992 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-1437145
20.
Identification of Shc docking site on Ret tyrosine kinase.
Oncogene
; 14(7): 773-82, 1997 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-9047384